LION BIOTECHNOLOGIES INC's ticker is LBIO and the CUSIP is 53619R102. A total of 93 filers reported holding LION BIOTECHNOLOGIES INC in Q3 2016. The put-call ratio across all filers is 1.97 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $186,000 | -83.6% | 25,000 | -84.6% | 0.00% | -100.0% |
Q4 2016 | $1,131,000 | -53.1% | 162,770 | -44.4% | 0.00% | 0.0% |
Q3 2016 | $2,412,000 | +6.9% | 293,008 | +5.1% | 0.00% | 0.0% |
Q2 2016 | $2,257,000 | +60.5% | 278,706 | +0.7% | 0.00% | 0.0% |
Q1 2016 | $1,406,000 | -39.6% | 276,715 | -8.2% | 0.00% | -50.0% |
Q4 2015 | $2,326,000 | +12.8% | 301,319 | -15.8% | 0.00% | +100.0% |
Q3 2015 | $2,062,000 | -29.7% | 358,000 | +11.8% | 0.00% | -50.0% |
Q2 2015 | $2,935,000 | +19.1% | 320,100 | +57.3% | 0.00% | 0.0% |
Q1 2015 | $2,464,000 | – | 203,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACUTA CAPITAL PARTNERS, LLC | 3,232,416 | $26,183,000 | 12.58% |
Avoro Capital Advisors LLC | 4,338,557 | $35,142,000 | 7.81% |
FRAZIER MANAGEMENT LLC | 774,720 | $6,275,000 | 5.00% |
Broadfin Capital, LLC | 3,170,759 | $25,683,000 | 2.50% |
Perceptive Advisors | 3,611,976 | $29,257,000 | 2.03% |
Ghost Tree Capital, LLC | 700,000 | $5,670,000 | 1.64% |
Opaleye Management Inc. | 260,000 | $2,106,000 | 1.41% |
Rhenman & Partners Asset Management AB | 650,000 | $5,265,000 | 0.94% |
QVT Financial LP | 1,598,309 | $12,946,000 | 0.89% |
Cormorant Asset Management, LP | 505,941 | $4,098,000 | 0.58% |